deoxycytidine has been researched along with Uterine Cervical Neoplasms in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.23) | 18.7374 |
| 1990's | 3 (3.70) | 18.2507 |
| 2000's | 41 (50.62) | 29.6817 |
| 2010's | 32 (39.51) | 24.3611 |
| 2020's | 4 (4.94) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, XR; Liu, RF; Zou, MJ | 1 |
| Abdo Filho, E; Aranha, AS; Bonadio, RC; Carvalho, HA; da Costa, SCS; de Freitas, D; Dias Genta, MLN; Estevez-Diz, MDP; Ferreira, PAO; Gabrielli, FCG; Machado, KK; Miranda, VC; Scaranti, M | 1 |
| Bonadio, R; da Costa, S; de Bock, GH; Del Pilar Estevez Diz, M; Dornellas, A; Nunes de Arruda, F; Pereira, D | 1 |
| Aps, LRMM; Bitencourt Rodrigues, K; Cestari Moreno, N; de Oliveira Diniz, M; de Oliveira Silva, M; de Souza Ferreira, LC; Menck, CFM; Porchia, BFMM; Ramos da Silva, J; Ramos Moreno, AC; Silva Sales, N; Venceslau-Carvalho, AA | 1 |
| Arango-Bravo, E; Brau-Figueroa, H; Castro-Eguiluz, D; Cetina-Pérez, L; Cruz-Bautista, I; Galicia-Carmona, T; Jiménez-Lima, R; Lugo-Alferez, LA | 1 |
| Behera, UC; Modi, RR; Sheth, J; Singh, A | 1 |
| Cantú, D; Cetina, L; Chanona, J; Coronel, J; de la Garza, J; Dueñas-González, A; González-Enciso, A; Hinojosa, J; Jiménez-Lima, R; Montalvo, G; Mota, A; Muñoz, D; Pérez-Montiel, D; Poitevin, A; Rivera, L; Robles-Flores, J; Serrano, A; Trejo, E; Wegman, T | 1 |
| Clements, A; Cohn, DE; Smith, B; Straughn, JM; Tierney, BJ | 1 |
| Akbari, EH; Esmati, E; Hashemi, FA; Kalaghchi, B | 1 |
| Jiang, Y; Yang, L; Yuan, Z; Zhang, Y; Zhao, Q | 1 |
| Eskander, RN; Tewari, KS | 1 |
| Bydder, G; Bydder, M; Carmona, R; Gulaya, S; Mell, LK; Pritz, J; Vaida, F; Welch, CS; Williamson, CW; Zhu, H | 1 |
| Baranov, SB; Berlev, IV; Guseĭnov, KD; Maksimov, SIa; Mikaia, NA; Urmancheeva, AF | 1 |
| Katanyoo, K; Laopaiboon, M; Lumbiganon, P; Manusirivithaya, S; Supawattanabodee, B; Tangjitgamol, S | 1 |
| Autorino, R; Fagotti, A; Fanfani, F; Ferrandina, G; Foti, E; Gallotta, V; Gambacorta, A; Scambia, G; Smaniotto, D; Tagliaferri, L; Valentini, V | 1 |
| Chang, CJ; Chang, TC; Chen, CH; Chou, HH; Hong, JH; Huang, EY; Huang, HJ; Huang, KG; Lai, CH; Lin, H; Liou, JD; Liou, WS; Liu, FY; Tseng, CW; Wang, CC; Yang, LY | 1 |
| Akise, Y; Hashimoto, S; Kutsuki, S; Miyazawa, M; Nishimoto, K; Uchida, A | 1 |
| Bazan-Perkins, B; Candelaria, M; Cantú, D; Cetina, L; Coronel, J; Dueñas-González, A; Flores, V; Garcia-Arias, A; Gonzalez, A; Rivera, L | 1 |
| Cupino, N; de Los Reyes, R; Domingo, E; Jin, K; Kamnerdsupaphon, P; Lertbutsayanukul, C; Lertsanguansinchai, P; Lorvidhaya, V; Syortin, T; Tharavichitkul, E; Vito-Cruz, E; Yoshihara, M | 1 |
| Benda, J; Boardman, CH; Cella, D; Cohn, DE; McMeekin, DS; Monk, BJ; Ramondetta, LM; Sill, MW | 1 |
| Jain, M; Mittal, B; Singh, H | 1 |
| Chen, YG; Hu, JM; Huang, Q; Qu, QX; Xie, F; Zhang, XG | 1 |
| Eastwood, A; Manca, A; Misso, K; Palmer, S; Paton, F; Paulden, M; Saramago, P | 1 |
| Chitapanarux, I; Hsieh, CY; Kamnerdsupaphon, P; Lertsanguansinchai, P; Lorvidhaya, V; Phromratanapongse, P; Sukthomya, V; Tharavichitkul, E | 1 |
| Benda, J; Boardman, CH; Cella, D; Cohn, D; Huang, HQ; McMeekin, DS; Monk, BJ; Ramondetta, L; Wenzel, L | 1 |
| Ahmed, M; Hassan, AH; Hussain, A; Priyani, A; Sadrieh, L; Sharma, C | 1 |
| Elghissassi, I; Errihani, H; Inrhaoun, H; Ismaili, N; M'rabti, H | 1 |
| Ahmed, M; Brahmbhatt, K; Hussain, A; Priyani, A; Sadrieh, L; Sharma, C | 1 |
| Thomas, G | 1 |
| Alcedo, JC; Barraclough, H; Beslija, S; Blair, JM; Casanova, L; Dueñas-González, A; Hameed, S; Orlando, M; Patel, F; Pattaranutaporn, P; Zarbá, JJ | 1 |
| Chan, S; Davidson, SE; Harden, S; McMahon, T; Paul, J; Rai, D; Reed, NS; Symonds, RP | 1 |
| Ahmed, M; Brahmbhatt, K; Hussain, A; Priyani, A; Rizvi, TA; Sharma, C | 1 |
| Cetina, L; Coronel, J; Dueñas-Gonzalez, A | 1 |
| Orlova, RV; Protasova, AE | 1 |
| Candelaria, M; Chavez-Blanco, A; de la Cruz-Hernandez, E; Diaz-Chavez, J; Dominguez, G; Duenas-Gonzalez, A; Gonzalez-Fierro, A; Perez-Cardenas, E; Soto-Reyes, E; Taja-Chayeb, L; Trejo-Becerril, C; Trujillo, JE | 1 |
| Hasegawa, K; Kato, R; Kawamura, K; Kobayashi, Y; Okamoto, H; Sekiya, T; Udagawa, Y | 1 |
| Barraclough, H; Dueňas-González, A; Orlando, M; Quinlivan, M; Zhou, Y | 1 |
| Barnett, JC; Chino, JP; Havrilesky, LJ; Jewell, EL; Leath, CA; Phippen, NT | 1 |
| O'Malley, DM; Salani, R | 1 |
| Markman, M | 1 |
| Chanona, G; De La Garza, J; Duenas-Gonzalez, A; Gonzalez-Enciso, A; Guadarrama, R; Lopez-Graniel, C; Mohar, A; Mota, A; Rivera, L | 1 |
| Barsoum, J; Brickelmaier, M; Carmillo, A; Goelz, S; Qin, XQ | 1 |
| Clippe, C; Ligneau, B; Trillet-Lenoir, V | 1 |
| Chanona, G; de la Garza, J; Dueñas-González, A; Gomez, E; González, A; López-Graniel, C; Mohar, A; Rivera, L; Trejo-Becerril, C | 1 |
| Eda, H; Endoh, M; Hattori, K; Horii, I; Ishikawa, T; Ishitsuka, H; Kawashima, A; Kohchi, Y; Miwa, M; Oikawa, N; Shimma, N; Suda, H; Tanimura, H; Ura, M | 1 |
| Chávez-Blanco, A; Dueñas-González, A; García-López, P; González-Fierro, A; Lizano-Soberon, M; Mariscal, I; Pérez-Cárdenas, E; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Treviño-Cuevas, H; Wegman-Ostrosky, T | 1 |
| Arroyo, G; Castagnino, R; Gonzalez Jazey, P; Jaremtchuk, AV; Keropian, M; Mina, C; Zarbá, JJ | 1 |
| Bloss, JD; Mutch, DG | 1 |
| Chitapanarux, I; Kamnerdsupaphon, P; Lorvidhaya, V; Sukthomya, V; Tonusin, A | 1 |
| Candelaria, M; Cetina, L; de la Garza, J; Dueñas-González, A; Rivera, L | 1 |
| Blessing, J; Cohn, DE; Schilder, RJ | 1 |
| Azria, D; Coelho, M; Culine, S; Dubois, JB; Larbouret, C; Lemanski, C; Pèlegrin, A; Serre, A; Ychou, M | 1 |
| Cetina-Perez, L; de La Garza, J; Dueñas-González, A; Gómez-Gonzalez, E; Gonzalez-Enciso, A; Lopez-Graniel, C; Mohar, A; Montalvo-Esquivel, G; Muñoz-Gonzalez, D; Rivera-Rubi, L; Robles-Flores, J; Vazquez-Govea, E | 1 |
| Lertkhachonsuk, R; Sirisabya, N; Sittisomwong, T; Termrungruanglert, W; Tresukosol, D; Vasuratna, A | 1 |
| Atkinson, EN; Bodurka, DC; Brown, J; Jenkins, AD; Johnston, T; Levenback, C; Ramondetta, LM; Sun, C; Wolf, JK | 1 |
| Chan, S; Curto, J; Habeshaw, T; Joynson, C; Reed, N; Stokes, Z; Symonds, P | 1 |
| Brom, R; Candelaria, M; Cantu, D; Cetina, L; Chanona, J; de la Garza, J; Dolores, R; Duenas-Gonzalez, A; Gonzalez, A; Lopez-Graniel, C; Uribe, J | 1 |
| Blessing, JA; Brewer, CA; Lele, S; McMeekin, DS; Nagourney, RA; Zweizig, SL | 1 |
| Aguiluz, M; Andrade, S; Erazo, M; Flores, C; Pineda, C; Santillana, S; Umanzor, J | 1 |
| Garcia, R; Goff, BA; Greer, B; Koh, WJ; Swensen, RE; Swisher, EM; Tamimi, H | 1 |
| Atkinson, T; Campos, S; Duska, L; Fuller, AF; Goodman, A; Krasner, CN; Matulonis, UA; Penson, RT; Seiden, MV; Verrill, C | 1 |
| Gibb, RK; Grigsby, PW; Mutch, DG; Powell, MA; Rader, JS; Viviano, D; Wright, JD | 1 |
| Aimpun, P; Jarruwale, P; Tanapat, Y | 1 |
| Chan, S; Dhadda, AS | 1 |
| Blessing, JA; Darcy, KM; Garcia, AA; Hannigan, E; Lenz, HJ; Moore, DH; Zhang, W | 1 |
| Bae, DS; Choi, CH; Huh, SJ; Kim, BG; Kim, TJ; Kim, WY; Lee, JH; Lee, JW; Nam, HR | 1 |
| Degeest, K; Fusco, N; McMeekin, S; Rose, PG | 1 |
| Benjapibal, M; Inthasorn, P; Leelaphatanadit, C; Therasakvichya, S; Thirapakawong, C | 1 |
| Chumworathayi, B; Krusun, S; Luanratanakorn, S; Pattamadilok, J; Tangvorapongchai, V; Yuenyao, P | 1 |
| Eisenhauer, EA; Vermorken, JB | 1 |
| Fukuoka, M; Furuse, K; Hasegawa, K; Hirabayashi, K; Nakajima, H; Niitani, H; Noda, K; Ogura, T; Taguchi, T | 1 |
| Coucke, PA; Guillou, L; Li, YX; Sun, LQ | 1 |
| Brader, KR; Burnett, AF; Garcia, AA; Morrow, CP; Muderspach, LI; Roman, LD | 1 |
| Blessing, JA; Mangan, CE; Morgan, M; Rader, JS; Schilder, RJ | 1 |
| D'Agostino, G; Genovesi, D; Greggi, S; Lorusso, D; Scambia, G; Smaniotto, D | 1 |
| de la Guerra, J; Dueñas-Gonzalez, A; Hinojosa-García, LM; López-Graniel, C; Maldonado, V; Meléndez-Zagla, J | 1 |
| Chansilpa, Y; Ieumwananontachai, N; Pattaranutaporn, P; Thephamongkhol, K; Therasakvichya, S; Thirapakawong, C | 1 |
| Chanona, J; De la Garza, J; Dueñas-Gonzalez, A; Florentino, R; Gonzalez, A; Guadarrama, R; Hinojosa, LM; Lopez-Graniel, C; Maldonado, V; Meléndez, J; Mohar, A; Mota, A; Muñoz, D; Reyes, M; Robles, E; Solorza, G | 1 |
| Dueñas-Gonzalez, A; Hernández, P; Maldonado, V; Meléndez-Zajgla, J; Olivera, P; Pérez-Pastenes, MA; Zárate, A | 1 |
| Bagrova, SG | 1 |
| Cooper, GM | 1 |
9 review(s) available for deoxycytidine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Mass Screening; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Taxoids; Topotecan; Uterine Cervical Neoplasms | 2014 |
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Mitomycin; Neoplasm Staging; Randomized Controlled Trials as Topic; Uterine Cervical Neoplasms | 2014 |
Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cost-Benefit Analysis; Cross-Linking Reagents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Quality of Life; Quality-Adjusted Life Years; Radiation-Sensitizing Agents; Topotecan; Treatment Outcome; United Kingdom; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 2010 |
Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Neoplasm Metastasis; Paclitaxel; Radiation-Sensitizing Agents; Survival Rate; Topotecan; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 2011 |
Chemoradiation in the management of cervix cancer: current status and future directions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Uterine Cervical Neoplasms | 2013 |
[Role of gemcitabine in the treatment of other malignant tumors].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Female; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Treatment Outcome; Uterine Cervical Neoplasms | 2002 |
Gemcitabine in cervical cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 2003 |
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mice; Neoplasms; Otorhinolaryngologic Neoplasms; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Rats; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 2004 |
New drugs in gynecologic oncology.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Clinical Trials as Topic; Deoxycytidine; Endometrial Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Platinum Compounds; Uterine Cervical Neoplasms | 1996 |
42 trial(s) available for deoxycytidine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Patient Compliance; Progression-Free Survival; Uterine Cervical Neoplasms; Young Adult | 2019 |
Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Quality of Life; Uterine Cervical Neoplasms | 2020 |
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients.
Topics: Adult; Aged; Brachytherapy; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Hysterectomy; Middle Aged; Radiation-Sensitizing Agents; Survival; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2013 |
[ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer].
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Paclitaxel; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 2013 |
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Deoxycytidine; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Pelvis; Prospective Studies; Radiotherapy, Conformal; Survival; Uterine Cervical Neoplasms | 2014 |
A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms | 2015 |
Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brachytherapy; Capecitabine; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Middle Aged; Survival Rate; Uterine Cervical Neoplasms | 2009 |
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Fatigue; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Paclitaxel; Prognosis; Quality of Life; Topotecan; Treatment Outcome; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine; Young Adult | 2009 |
Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2010 |
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Topotecan; Treatment Outcome; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 2010 |
Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 2011 |
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Infant; Infant, Newborn; Uterine Cervical Neoplasms | 2011 |
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Quality of Life; Taxoids; Uterine Cervical Neoplasms | 2011 |
Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Tumor Burden; Uterine Cervical Neoplasms | 2012 |
Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Female; Gemcitabine; Humans; Markov Chains; Middle Aged; Models, Statistical; Neoplasm Staging; Quality of Life; Quality-Adjusted Life Years; Survival Analysis; Treatment Outcome; United States; Uterine Cervical Neoplasms | 2012 |
Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2002 |
Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Uterine Cervical Neoplasms | 2003 |
A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Confidence Intervals; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Cisplatin and gemcitabine in patients with metastatic cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms | 2004 |
Chemoradiation with gemcitabine for cervical cancer in patients with renal failure.
Topics: Brachytherapy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Creatinine; Deoxycytidine; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Kidney Function Tests; Mexico; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Renal Insufficiency; Time Factors; Treatment Outcome; Urethral Obstruction; Uterine Cervical Neoplasms | 2004 |
Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinoma, Adenosquamous; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms | 2005 |
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Confidence Intervals; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2005 |
Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Uterine Cervical Neoplasms | 2005 |
Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Uterine Cervical Neoplasms | 2005 |
Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Hematologic Diseases; Humans; Middle Aged; Radiotherapy; Uterine Cervical Neoplasms | 2005 |
Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms | 2006 |
Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Uterine Cervical Neoplasms | 2006 |
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Uterine Cervical Neoplasms | 2006 |
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 2006 |
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Protein Biosynthesis; Thymidine Phosphorylase; Thymidylate Synthase; Uterine Cervical Neoplasms | 2007 |
Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Comorbidity; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Diseases; Gemcitabine; Humans; Incidence; Korea; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2007 |
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Pelvis; Radiotherapy, Adjuvant; United States; Uterine Cervical Neoplasms | 2007 |
A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 2007 |
Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Middle Aged; Thailand; Treatment Outcome; Uterine Cervical Neoplasms | 2007 |
[An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Breast Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Stomach Neoplasms; Uterine Cervical Neoplasms | 1996 |
A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Cervical Neoplasms | 2000 |
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms | 2000 |
Gemcitabine is ineffective in recurrent, preirradiated cervical cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Disease-Free Survival; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Cervical Neoplasms | 2000 |
Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Uterine Cervical Neoplasms | 2001 |
Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy; Uterine Cervical Neoplasms | 2001 |
A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
[Results of phase II clinical trial of cycloplatam in refractory solid tumors].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Pleural Neoplasms; Pleurisy; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine | 2001 |
30 other study(ies) available for deoxycytidine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Discs Large Homolog 1 Protein; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Nude; MicroRNAs; RNA, Long Noncoding; Uterine Cervical Neoplasms | 2022 |
A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model.
Topics: Alphapapillomavirus; Animals; CD8-Positive T-Lymphocytes; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Vaccines, DNA | 2021 |
Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Uterine Cervical Neoplasms | 2022 |
Bilateral macular infarction after gemcitabine and carboplatin chemotherapy.
Topics: Adult; Antimetabolites, Antineoplastic; Carboplatin; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Humans; Infarction; Macula Lutea; Retinal Diseases; Uterine Cervical Neoplasms; Visual Acuity | 2018 |
Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hospitalization; Humans; Models, Econometric; Neutropenia; Uterine Cervical Neoplasms | 2013 |
Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cobalt Radioisotopes; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Uterine Cervical Neoplasms; Young Adult | 2013 |
Fat composition changes in bone marrow during chemotherapy and radiation therapy.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Capecitabine; Cervical Vertebrae; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Endometrial Neoplasms; Female; Fluorouracil; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Paclitaxel; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Spine; Thoracic Vertebrae; Uterine Cervical Neoplasms | 2014 |
[Neoadjuvant chemoradiotherapy in the combined treatment of patients with stage IB2-III cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Russia; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Deoxycytidine; Female; Gamma Rays; Gastrointestinal Hemorrhage; Gemcitabine; Humans; Radiation-Sensitizing Agents; Radiodermatitis; Rectum; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 2016 |
Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Hysterectomy; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer.
Topics: Adult; Deoxycytidine; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Homozygote; Humans; India; Middle Aged; Neoplasm Staging; Odds Ratio; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Factors; Smoking; Thymidine; Tobacco, Smokeless; Transforming Growth Factor beta1; Uterine Cervical Neoplasms | 2009 |
Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; CD40 Antigens; Cell Line, Tumor; Cell Proliferation; Cell Separation; Deoxycytidine; Enzyme Activation; Female; Flow Cytometry; Gemcitabine; Humans; Immunohistochemistry; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Uterine Cervical Neoplasms | 2011 |
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells.
Topics: Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Inflammation; Interleukin-1beta; Isothiocyanates; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Sulfoxides; Thiocyanates; Uterine Cervical Neoplasms | 2011 |
Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Down-Regulation; Drug Synergism; Eugenol; Female; Gemcitabine; HeLa Cells; Humans; Interleukin-1beta; Isothiocyanates; Proto-Oncogene Proteins c-bcl-2; Sulfoxides; Thiocyanates; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2012 |
Are we making progress in curing advanced cervical cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Developing Countries; Female; Gemcitabine; Humans; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Uterine Cervical Neoplasms | 2011 |
Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Eugenol; Female; Gemcitabine; HeLa Cells; Humans; Uterine Cervical Neoplasms | 2011 |
[Results of chemotherapy for gynecologic cancer patients in ambulatory care].
Topics: Ambulatory Care; Ambulatory Care Facilities; Anemia, Hypochromic; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Endometrial Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Hospitalization; Humans; Middle Aged; Neutropenia; Outpatients; Ovarian Neoplasms; Paclitaxel; Quality of Life; Russia; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.
Topics: Antimetabolites, Antineoplastic; Blotting, Western; Cell Culture Techniques; Cell Line, Tumor; Chromatin Immunoprecipitation; Deoxycytidine; DNA Primers; Drug Resistance, Neoplasm; Epigenesis, Genetic; Equilibrative Nucleoside Transporter 1; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone Deacetylases; Histone-Lysine N-Methyltransferase; Humans; Hydralazine; Reverse Transcriptase Polymerase Chain Reaction; Uterine Cervical Neoplasms | 2012 |
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Peplomycin; Thymidine Phosphorylase; Uterine Cervical Neoplasms | 2012 |
Here it comes....the role of cost-effective analysis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Uterine Cervical Neoplasms | 2012 |
Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Death; Cell Division; Cisplatin; Deoxycytidine; Drug Synergism; Female; Fluorouracil; Gemcitabine; Humans; Interferon-beta; Lung Neoplasms; Paclitaxel; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Non-Small-Cell Lung; Cytidine Deaminase; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Design; Drug Stability; Esterases; Female; Fluorouracil; Humans; Lung Neoplasms; Mice; Oxidoreductases; Prodrugs; Thymidine Phosphorylase; Tissue Distribution; Uracil; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2003 |
Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; DNA, Neoplasm; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Gemcitabine; HeLa Cells; Humans; In Vitro Techniques; Mice; Mice, Nude; Middle Aged; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Nucleosomes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Rats; Rats, Wistar; Tumor Virus Infections; Uterine Cervical Neoplasms | 2003 |
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Carboplatin; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pilot Projects; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Retrospective Studies; Uterine Cervical Neoplasms | 2006 |
Gemcitabine and radiotherapy in the treatment of uterine cervical cancer patients at Phramongkutklao Hospital.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Retrospective Studies; Survival Rate; Thailand; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer.
Topics: Adult; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Female; Femur Head Necrosis; Fluorouracil; Humans; Uterine Cervical Neoplasms; X-Rays | 2006 |
(E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Combined Modality Therapy; Deoxycytidine; Female; Glioblastoma; Humans; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 1998 |
Gemcitabine activity in cervical cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cisplatin; Deoxycytidine; DNA Damage; Drug Interactions; Female; Gemcitabine; HeLa Cells; Humans; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |
Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.
Topics: Adult; Animals; Bromides; Bromodeoxyuridine; Carcinoma; Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Deoxycytidine; Deoxycytidine Monophosphate; Deoxyribonucleosides; Deoxyribonucleotides; DNA; DNA, Neoplasm; Female; Humans; Kidney; Laryngeal Neoplasms; Middle Aged; Phosphorus; Phosphotransferases; Simplexvirus; Tritium; Uterine Cervical Neoplasms; Viral Plaque Assay | 1973 |